Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sandoz Launches First Generic of Esbriet.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Abstract:
The article reports that Sandoz, a global leader in generic and biosimilar medicines, today announced the U.S. launch of its generic pirfenidone, the first AB-rated (fully substitutable) equivalent to Genentech's Esbriet, to treat patients with idiopathic pulmonary fibrosis (IPF). It mentions that Sandoz developed the medicine in-house and continue to build our expertise and infrastructure to support our long-term commitment to grow our respiratory portfolio.
No Comments.